How Can Pharmacogenomics Prevent Adverse Drug Reactions?
Adverse drug reactions (ADRs) are a significant concern in pediatric care. By understanding the genetic factors that affect drug metabolism, healthcare providers can predict which children are at higher risk for ADRs. For instance, variations in genes like CYP2D6 and CYP3A4 can influence how children metabolize certain medications, such as codeine or carbamazepine. Pharmacogenomic testing can identify these genetic variations, allowing for more personalized and safer medication choices.
